TGF-β-Smad inhibitor LY2109761, Purity ≥98%

Cat. No.: X23-10-ZQ814

TGF-β-Smad inhibitor LY2109761, Purity ≥98%

Synonym: LY2109761; 700874-71-1; LY 2109761; LY-2109761; 4-(2-((4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morpholine; DV3HD37UBK; 4-(5,6-Dihydro-2-(2-pyridinyl)-4H-pyrrolo(1,2-b)pyrazol-3-yl)-7-(2-(4-morpholinyl)ethoxy)quinoline; TGF-β-Smad inhibitor

  • MDL: MFCD12923354
  • CAS Number: 700874-71-1
  • Compound CID: 11655119
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
LY2109761, soluble in DMSO and insoluble in ethanol and water, is a potent and specific inhibitor of TGF-β-Smad signaling pathway activation.
Molecular Weight
441.5
Molecular Formula
C26H27N5O2
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 2 mg/mL (4.52 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
LY2109761 can be used to study its dual inhibition of TGF-β receptor I and II kinases and its implications in cancer therapy.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0